Xcout IntelKorro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Subscribe to see Korro Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Korro Bio, Inc. at a glance
Korro Bio, Inc. is a biotech company headquartered in Cambridge, United States. It is publicly listed (KRRO) with a market capitalisation of $105.3M. Xcout tracks 17 named people at Korro Bio, Inc., including Ram Aiyar (Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director). Xcout recorded 5 job postings from Korro Bio, Inc. in the last 90 days.
Korro Bio, Inc. leadership
- Ram AiyarChief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director
- Todd ChappellChief Operating Officer
- Loic VincentChief Scientific Officer
- Stephanie EngelsChief People Officer
- Jean-Francois FormelaCo-Founder & Director
- Andrew FraleyCo-Founder & Advisor
11 more named people on record for Korro Bio, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Korro Bio, Inc.
Xcout recorded 5 job postings from Korro Bio, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Korro Bio, Inc.'s hiring signals →
Investors
Tech stack
Korro Bio, Inc. competitors
A few of Korro Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
AIRNA Corporation, Inc. is a biotechnology company headquartered in the United States, focused on delivering precision therapies through its innovative RNA editing platform.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
KOMO Biosciences is a biotechnology research company headquartered in Cambridge, Massachusetts. The company specializes in next-generation precision genome engineering driven by highly efficient, evolved integrases.
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Get Korro Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Korro Bio, Inc. in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access